James Basta, J.D., serves as the Executive Vice President, General Counsel, and Corporate Secretary at Intellia Therapeutics Inc., a leading genome editing company focused on developing curative therapeutics. In his role, Basta is responsible for overseeing all legal matters, including corporate governance, intellectual property, and compliance, ensuring that the company's operations align with legal and ethical standards. His strategic leadership is crucial in navigating the complex regulatory landscape of the biotechnology industry, thereby supporting Intellia's mission to deliver life-changing treatments to patients worldwide. Prior to joining Intellia Therapeutics, Basta amassed a wealth of experience in the life sciences sector. He previously held the position of Senior Vice President and General Counsel at Alexion Pharmaceuticals, where he played a pivotal role in the company's growth and success, including overseeing significant acquisitions and strategic partnerships. Basta's career also includes a tenure at Pfizer, where he served as Vice President and Assistant General Counsel, contributing to the company's legal strategy and operations. His extensive background in both pharmaceuticals and biotechnology has equipped him with the expertise necessary to drive Intellia's legal and corporate governance initiatives effectively. Basta's academic credentials are equally impressive, having earned his Juris Doctor from the University of Pennsylvania Law School. His commitment to excellence and deep understanding of the legal intricacies in the biotech industry have been instrumental in his achievements. At Intellia, Basta continues to leverage his skills to foster innovation and ensure that the company remains at the forefront of genome editing technology, contributing significantly to its goal of transforming patients' lives.